Skip to main content
KPC PHARMACEUTICALS, INC. logo

KPC PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · 600422 ISIN · CNE0000015P8 LEI · 3003007ZALHXKUFMKN96 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,728 across all filing types
Latest filing 2013-05-20 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600422

About KPC PHARMACEUTICALS, INC.

https://en.kpc.com.cn/

KPC Pharmaceuticals, Inc. specializes in the research, development, and manufacturing of pharmaceutical products, with a significant focus on natural and botanical medicines. The company is a global leader in the production of artemisinin-based anti-malarial treatments, including artemether and its derivatives. Its portfolio encompasses a wide range of therapeutic areas, notably cardiovascular and cerebrovascular health, where it utilizes Panax notoginseng saponins as a core component. KPC integrates traditional medicinal knowledge with modern pharmacological techniques to develop standardized botanical extracts and chemical drugs. The organization operates extensive production facilities and research centers dedicated to drug discovery and quality control. Its business activities extend to the distribution of healthcare products and the provision of medical services, aiming to provide comprehensive health solutions through innovation in natural medicine and biotechnology.

Recent filings

Filing Released Lang Actions
关于公开增发获得中国证券监督管理委员会发行审核委员会审核通过的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the approval of a public offering by the China Securities Regulatory Commission's issuance review committee. It states that the company has received approval for a public offering and will announce further details after receiving official written approval. The document length is only 441 characters, indicating it is a brief announcement rather than a detailed report. There are no financial statements or detailed financial data included. This fits the category of a Capital/Financing Update (CAP) as it relates to company fundraising activities and capital structure changes.
2013-05-20 Chinese
关于2012年授予股权激励所涉限制性股票第一次解锁的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Kunming Pharmaceutical Group Co., Ltd. regarding the first unlocking of restricted shares granted under the 2012 equity incentive plan. It details the number of shares unlocked, the conditions for unlocking, the approval and implementation of the equity incentive plan, and the resulting changes in shareholding structure. The document is a formal public announcement about a specific equity incentive event and share unlocking, not a full financial report or management discussion. It does not contain financial statements or detailed financial analysis. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other specific categories.
2013-05-20 Chinese
股权激励计划当期购买股份开始公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement from Kunming Pharmaceutical Group Co., Ltd. regarding the commencement of share repurchase under an equity incentive plan. It details the purpose, basis, method, price, quantity, funding source, and expected impact of the share repurchase. The document includes specific dates, share quantities, and financial figures related to the repurchase but does not contain comprehensive financial statements or quarterly/yearly financial results. It is a formal announcement about a capital action (share repurchase) related to employee stock incentives. Therefore, it fits best under the category of Transaction in Own Shares (POS), which covers company buyback or sale of its own shares.
2013-05-10 Chinese
七届六次董事会决议公告
Board/Management Information Classification · 95% confidence The document is a board resolution announcement from Kunming Pharmaceutical Group Co., Ltd. It details decisions made at the company's seventh board meeting, including approval of a restricted stock incentive plan, share repurchase plan, and performance rewards for executives. The text includes voting results and mentions the board meeting date and participants. There is no financial data, earnings information, or detailed report content. The document is an announcement of board decisions, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report itself but a formal announcement of board resolutions.
2013-05-10 Chinese
关于公司大股东减持的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a short announcement regarding the reduction of shareholding by a major shareholder of the company. It details the number of shares sold and the percentage of total share capital reduced. There is no financial report, earnings data, or management discussion. The content fits the definition of a Major Shareholding Notification, which reports changes in significant share ownership levels crossing thresholds. The document length is short and focused solely on shareholding changes, confirming it is not a full report or other type of filing.
2013-05-08 Chinese
七届五次董事会决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of Kunming Pharmaceutical Group Co., Ltd. It includes details about the meeting date, voting results, and specific agenda items such as approval of the 2013 first quarter report, purchase of a pharmaceutical product, and acquisition of a subsidiary's equity. The document is titled as a "Board of Directors Meeting Resolution Announcement" and does not contain the full quarterly report or detailed financial statements itself, but rather references the 2013 first quarter report. The length is short (1780 characters), and the content is focused on board decisions and approvals rather than the report itself. Therefore, this document fits best under the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2013-04-24 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.